BARBATO, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 948
EU - Europa 461
AS - Asia 226
SA - Sud America 8
AF - Africa 1
Totale 1.644
Nazione #
US - Stati Uniti d'America 940
SE - Svezia 164
SG - Singapore 141
IT - Italia 106
IN - India 47
IE - Irlanda 39
GB - Regno Unito 32
DE - Germania 24
UA - Ucraina 22
CN - Cina 20
BE - Belgio 17
FI - Finlandia 17
NL - Olanda 17
JP - Giappone 10
BR - Brasile 7
CH - Svizzera 7
MX - Messico 5
HK - Hong Kong 4
RO - Romania 4
CA - Canada 3
LV - Lettonia 2
MT - Malta 2
NO - Norvegia 2
RU - Federazione Russa 2
TW - Taiwan 2
AR - Argentina 1
BG - Bulgaria 1
ES - Italia 1
FR - Francia 1
IL - Israele 1
MA - Marocco 1
PT - Portogallo 1
TR - Turchia 1
Totale 1.644
Città #
Boardman 182
Fairfield 111
Seattle 68
Woodbridge 61
Singapore 54
Rome 46
Ashburn 45
Dublin 39
Wilmington 39
Cambridge 34
Los Angeles 34
Houston 26
Chandler 23
New York 22
Princeton 18
West Jordan 18
Groningen 17
London 17
San Paolo di Civitate 15
Liège 12
Plano 12
Dearborn 9
Jacksonville 9
Lawrence 9
Ann Arbor 8
Boston 8
Beijing 7
Des Moines 7
Pune 6
Bern 5
Brussels 5
Helsinki 5
Latina 5
Mexico City 5
Millbury 5
San Diego 5
Kilburn 4
Munich 4
São Paulo 4
Americana 3
Andover 3
Bühl 3
Florence 3
Phoenix 3
Shanghai 3
Southend 3
Umeda 3
Bari 2
Bodø 2
Clifton 2
Falls Church 2
Fremont 2
Gallese 2
Għaxaq 2
Hong Kong 2
Lappeenranta 2
Milan 2
Milazzo 2
Monza 2
Santa Clara 2
Southend-on-Sea 2
Taichung 2
Tappahannock 2
Telgate 2
Toronto 2
Toyonaka 2
Zurich 2
Amarante 1
Ankara 1
Bologna 1
Caivano 1
Campobasso 1
Council Bluffs 1
Erlangen 1
Federal 1
Gunzenhausen 1
Hamburg 1
Hefei 1
Jinan 1
Nanchang 1
Northampton 1
Padova 1
Palermo 1
Paris 1
Portland 1
Prescot 1
Saint Louis 1
Salé 1
San Francisco 1
San Mateo 1
Savoy 1
Schweinfurt 1
Shenyang 1
Shimla 1
Sofia 1
St Petersburg 1
Tel Aviv 1
Terni 1
Torremolinos 1
Wandsworth 1
Totale 1.100
Nome #
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP 88
Human coronary atherosclerosis modulates cardiac natriuretic peptide release 71
T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients 65
NT-proANP circulating level is a prognostic marker in stable ischemic heart disease 64
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for reduction of myocardial damage during angioplasty [ARMYDA-8 RELOAD-ACS] trial) 58
C2238 Atrial Natriuretic Peptide Molecular Variant Is Associated With Endothelial Damage and Dysfunction Through Natriuretic Peptide Receptor C Signaling 58
Insulin modulation of an endothelial nitric oxide component present in the alpha-2 and beta-adrenergic responses in human forearm 56
Influence of rs5065 Atrial Natriuretic Peptide Gene Variant on Coronary Artery Disease 55
Systemic hypertension and coronary artery disease: the link 49
α2A-adrenergic receptor polymorphism potentiates platelet reactivity in patients with stable coronary artery disease carrying the cytochrome P450 2C19*2 genetic variant 42
null 40
FFRCT and CT perfusion. A review on the evaluation of functional impact of coronary artery stenosis by cardiac CT 30
Cardiovascular risk and the COVID-19 pandemic: a retrospective observational study in a population of healthcare professionals 29
Graft patency and progression of coronary artery disease after CABG assessed by angiography-derived fractional flow reserve 26
Functional assessment of coronary atherosclerosis in the catheterization laboratory: the key role of fractional flow reserve. 22
SARS-CoV-2 Related Myocarditis. What We Know So Far 21
Contemporary management of calcified coronary lesions 17
Role of adrenergic receptors in human coronary vasomotion 16
Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy 15
Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment 13
A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve 13
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome. A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients 12
CARDIAC BETA ARK1 UPREGULATION INDUCED BY CHRONIC SALT DEPRIVATION IN RATS 11
Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME). 5-year follow-up of a randomised controlled trial 11
Adjunctive Thrombus Aspiration in Primary Percutaneous Coronary Intervention in Real-world Patients With St-elevation Myocardial Infarction 11
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-Month follow-up results of the EXCELLA II study 11
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery. Surgery After Stenting 2 10
ST-elevation myocardial infarction and multivessel disease: predictors of non-culprit lesion revascularization 10
Response to letter regarding article, "revascularization decisions in patients with stable angina and intermediate lesions: Results of the international survey on interventional strategy" 10
Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents. The PROACTIVE trial 10
A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study 10
Fractional flow reserve in patients with reduced ejection fraction 10
St. John's Wort in patients non-responders to clopidogrel undergoing percutaneous coronary intervention: a single-center randomized open-label trial (St. John's Trial) 9
Fractional flow reserve calculation from 3-dimensional quantitative coronary angiography and TIMI frame count: a fast computer model to quantify the functional significance of moderately obstructed coronary arteries 9
Acute coronary syndromes in patients with multivessel disease: the key role of optical coherence tomography 9
High cholesterol levels are associated with coronary microvascular dysfunction 9
Role of β2 adrenergic receptors in human atherosclerotic coronary arteries 9
High platelet reactivity and periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention. A significant association beyond definitions 9
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 9
Global fractional flow reserve value predicts 5-year outcomes in patients with coronary atherosclerosis but without ischemia 9
Atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac amyloidosis: from clinical management to catheter ablation indication 8
Coronary Artery Spasm and Prognosis in Patients on Optimal Chronic Antispasmodic Therapy 8
Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold. Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 Years 8
A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study 8
Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk. Another Brick in the Wall 8
Role of the sympathetic nervous system in cardiac remodeling in hypertension 8
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 8
Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome 8
A personal tribute to Maurizio Galderisi 8
Response to letter to the editor regarding article "Macrophage migration inhibitory factor (MIF) is associated with degree of collateralization in patients with totally occluded coronary arteries" 8
Clinical Outcomes Following Coronary Bifurcation PCI Techniques. A Systematic Review and Network Meta-Analysis Comprising 5,711 Patients 8
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation 8
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study 8
Intracoronary Adenosine: Dose-Response Relationship With Hyperemia 8
Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease. Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) 8
Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats 8
Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent. 5-year results of the CENTURY II randomized clinical trial 8
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial 8
The impact of the extent of side branch disease on outcomes following bifurcation stenting 7
Long-term follow-up after fractional flow reserve-guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis 7
Evolving patterns in procedural techniques and strategies in patients with heavily calcified coronary lesions 7
2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent 7
Fractional flow reserve (FFR) as a guide to treat coronary artery disease 7
Coronary artery bypass grafting or fractional flow reserve-guided percutaneous coronary intervention in diabetic patients with multivessel disease 7
Effect of Sex on Outcomes of Coronary Rotational Atherectomy Percutaneous Coronary Intervention (From the European Multicenter Euro4C Registry) 7
ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation 7
Mapping interventional cardiology in Europe: the european association of percutaneous cardiovascular interventions (EAPCI) atlas project 7
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention 7
A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial 7
Autocrine bradykinin release promotes ischemic preconditioning-induced cytoprotection in bovine aortic endothelial cells 7
Mid-term outcomes after percutaneous interventions in coronary bifurcations 7
Heart failure with preserved ejection fraction or non-cardiac dyspnea in paroxysmal atrial fibrillation.The role of left atrial strain 7
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 7
Drug eluting stents with bioresorbable polymer: the menu 7
Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel 7
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions. meta-analysis of individual patient data 7
2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes 7
Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pullback pressure gradients 7
Endothelial dysfunction in patients with spontaneous coronary artery dissection. another brick in the failing coronary wall? 7
Role of the sympathetic nervous system in cardiac remodeling in hypertension 7
Contemporary Management of Stable Coronary Artery Disease 7
Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study 7
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 7
Evaluation of epicardial coronary resistance using computed tomography angiography. A Proof Concept 7
Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography. Validation with Magnetic Resonance Imaging 7
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 7
Mapping interventional cardiology in Europe. proceedings of the 3rd Summit of the European Association of Percutaneous Cardiovascular Interventions 6
From fallacies to reality. Focus on fractional flow reserve 6
New Volumetric Analysis Method for Stent Expansion and its Correlation With Final Fractional Flow Reserve and Clinical Outcome: An ILUMIEN I Substudy 6
Sex Differences in Adenosine-Free Coronary Pressure Indexes: A CONTRAST Substudy 6
Significance of Intermediate Values of Fractional Flow Reserve in Patients With Coronary Artery Disease 6
Insulin resistance the hinge between hypertension and type 2 diabetes 6
Preoperative functional assessment of the left main and postoperative side branch evaluation 6
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction. Results from the POPular Genetics Trial 6
Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus 6
Severely calcified coronary stenoses: Novel challenges, old remedy 6
Edge effect after intracoronary beta radiation brachytherapy and bare metal stent implantation: the pathway for very late stent failure 6
Randomized Comparison of Optical Coherence Tomography Versus Angiography to Guide Bioresorbable Vascular Scaffold Implantation. The OPTICO BVS Study 6
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers). a multicentre, open-label, randomised non-inferiority trial 6
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease 6
Totale 1.460
Categoria #
all - tutte 24.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201964 0 0 0 0 0 0 0 0 0 0 35 29
2019/2020199 23 9 3 9 19 30 29 24 25 15 7 6
2020/202191 7 10 0 6 1 6 26 9 10 5 10 1
2021/2022145 0 4 24 7 31 3 3 19 5 9 14 26
2022/20231.342 30 28 4 5 462 79 404 226 43 4 36 21
2023/2024980 28 55 26 41 39 53 200 183 123 231 1 0
Totale 2.899